SLBT
SL Science Holding Limited Ordinary Shares
NASDAQ · Healthcare · Biotechnology · US
$1.11
−9.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 131.58x
- Price / sales
- 283.28x
- Price / cash flow
- -325.92x
Enterprise value
- Enterprise value
- $619.4M
- EV / sales
- 281.89x
- EV / EBITDA
- -165.44x
- EV / EBIT
- -161.40x
- Market cap
- $622.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025